Across TCGA pan-cancer cohorts, RNU1-21P RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of RNU1-21P’s most consistent transcriptional readouts.
The strongest signal is observed in colon adenocarcinoma (COAD), where RNU1-21P RNA is more highly expressed in tumor relative to normal tissue. In most cancer types RNU1-21P is over-expressed in tumor.
COAD and LUAD are the cancer types where RNU1-21P tumor–normal differential expression is most reproducible.